Добавил:
kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:

Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3701_Библиотеки_им_академика_М_И_Перельмана

.pdf
Скачиваний:
0
Добавлен:
31.08.2026
Размер:
34 Мб
Скачать
Echocardiographic
391
https://t.me/medicina_free
http://dx.doi.org/10.5772/.107420
DOI:
Prognostic Factors in Pulmonary Hypertension
Novel Pathogenesis and Treatments for Cardiovascular Disease
392
https://t.me/medicina_free
References
[1] Galie N, Humbert M, Vachiery J-L,
GibbsS,LangI,TorbickiA,etal.2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension the joint task force for the diagnosis and treatment of pulmonary hypertension of the european society of cardiology (ESC) and the european respiratory society (ERS). European Heart Journal. 2016;37(1):67-119. DOI: 10.1093/ eurheartj/ehv317
[2] Armstrong WF. Thomas Ryan
Feigenbaum’s Echocardiography. eight ed. Wolters-Kluwer; 2019. ISBN-13 978-1-4511-9427-2
[3] Lang RM, Goldstein SA, Kronzon I,
Khanderhia BA, Saric M, Mor-Avi V. ASE’s Comprehensive Echocardiography. third ed. Philadelphia, PA: Elsevier; 2022. pp. 19103-2899. ISBN 9780323698306 Library of Congress Control Number 2020945518, printed in Canada
[4] Ginghină C, Popescu B. Ruxandra
Jurcuț Esențialul în ECOCARDIOGRAFIE. Editura Medicala Antaeus. 2nd ed. 2013. pp.259-274.www.antaeus.ro.ISBN24 978-606-8470-02-3
[5] Grünig E, Henn P, DAndrea A,
Claussen M, Ehlken N, Maier F, et al. Reference values for and determinants of right atrial area in healthy adults by 2-dimensional echocardiography. Circulation: Cardiovascular Imaging. 2013;6:117-124. DOI: 10.1161/ CIRCIMAGING.112.978031
[7] DiLorenzo MP, Bhatt SM. Laura
Mercer-Rosa How best to assess right ventricular function by echocardiography. Cardiology in the Young. 2015;25(8):1473-1481. DOI: 10.1017/S1047951115002255
[8] Benza RL, Miller DP, Gomberg-
Maitland M, Frantz RP, Foreman AJ, Coffey CS, et al. Predicting survival in pulmonary arterial hypertension insights from the registry to evaluate early and long-term pulmonary arterial hypertension disease management (REVEAL). Circulation. 2010;122:164-172
[9] Ho SY, Nihoyannopoulos P.
Anatomy, echocardiography, and normal right ventricular dimensions. Heart. 2006;92(Suppl. 1):i2-i13. DOI: 10.1136/hrt.2005.077875
[10] Zaidi A, Knight DS, Augustine DX,
Harkness A, Oxborough D, Pearce K, et al., editors. Vishal Sharma echocardiographic assessment of the right heart in adults: A practical guideline from the British Society of Echocardiography, 2020 British Society of Echocardiography. Echo Research & Practice. 2020;7:G19-G41. DOI: 10.1530/ ERP-19-0051
[11] Tamborini G, Pepi M, Galli CA,
Maltagliati A, Celeste F, Muratori M, et al. Feasibility and accuracy of a routine echocardiographic assessment of right ventricular function. International Journal of Cardiology. 2007;115(1): 86-89. DOI: 10.1016/j.ijcard.2006.01.017
[6] Parasuraman S, Walker S,
Loudon BL, Gollop ND, Wilson AM, Lowery C, et al. Assessment of pulmonary artery pressure by echocardiographyA comprehensive review. IJC Heart & Vasculature. 2016;
6(12):45-51
14
[12] Lang RM, Cameli M, Sade LE,
Faletra F, Fortuni F, Rossi A, et al. Imaging assessment of the right atrium: anatomy and function. European Heart Journal-Cardiovascular Imaging. 2022;23:867-884. DOI: 10.1093/ehjci/ jeac011
Echocardiographic
393
https://t.me/medicina_free
http://dx.doi.org/10.5772/.107420
DOI:
Prognostic Factors in Pulmonary Hypertension
[13] Jones N, Burns AT, Prior DL.
Echocardiographic assessment of the right ventricle–state of the art. Heart, Lung and Circulation. 2019;28: 1339-1350. DOI: 10.1016/j. hlc.2019.04.016
[14] Gripari P, Muratori M, Fusini L,
Tamborini G, Ali SG, Brusoni D, et al. Right ventricular dimensions and function: Why do we need a more accurate and quantitative imaging? Journal of Cardiovascular Echography. 2015;25(1):19-25. DOI: 10.4103/2211-
4122.158420
[15] Surkova E, Cosyns B, Gerber B,
Gimelli A, La Gerche A, Marsan NA. The dysfunctional right ventricle: The importance of multi-modality Imaging. European Heart Journal - Cardiovascular Imaging. 2022; 23:885-897. DOI: 10.1093/ ehjci/jeac037)
[16] Raymond RJ, Hinderliter AL,
Willis PW, IV DR, Caldwell EJ, Williams W, et al. Echocardiographic Predictors of Adverse Outcomes in Primary Pulmonary Hypertension. Journal of the American College of Cardiology. 2002;39(7):1214-1219
hypertension: A systematic review and meta-analysis. BMJ Open. 2020;10: e031316. DOI: 10.1136/bmjopen­2019-031316
[20] Forfia PR, Fisher MR, Thai SC,
Housten-Harris T, Hemnes AR, Borlaug BA, et al. Tricuspid annular displacement predicts survival in pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine. 2006;174:1034-1041
[21] Grapsa J, Nunes MCP, Tan TC,
Cabrita IZ, Coulter T, Smith BCF, et al. Echocardiographic and hemodynamic predictors of survival in precapillary pulmonary hypertension seven-year follow-up. Circulation: Cardiovascular Imaging. 2015;8:45-54. DOI: 10.1161/ CIRCIMAGING.114.002107
[22] Ghio S, Mercurio V, Fortuni F,
Forfia PR, Gall H, Ghofrani A, et al. A comprehensive echocardiographic method for risk stratification in pulmonary arterial hypertension. European Respiratory Journal. 2020;56 (3):2000513. DOI: 10.1183/
13993003.00513-2020
[17] Schneider OM, Binder T.
Echocardiographic evaluation of the right heart. Wiener Klinische Wochenschrift. 2018;130:413-420. DOI: 10.1007/s00508-018-1330-3
[18] Austin C, Alassas K, Burger C,
Safford R, Pagan R, Duello K, et al. Echocardiographic assessment of estimated right atrial pressure and size predicts mortality in pulmonary arterial hypertension. Chest. 2015;147(1): 198-208. DOI: 10.1378/chest.13-3035
[19] Liu K, Zhang C, Chen B, Li M,
Zhang P. Association between right atrial area measured by echocardiography and prognosis among pulmonary arterial
15
[23] Burkett DA, Patel SS, Mertens L,
Friedberg MK, Ivy D. Relationship between left ventricular geometry and invasive hemodynamics in pediatric pulmonary hypertension. Circulation: Cardiovascular Imaging. 2020;13: e009825. DOI: 10.1161/CIRCIMAGING.
119.009825
[24] Blanchard DG, Malouf PJ,
Gurudevan SV, Auger WR, Madani MM, Thistlethwaite P, et al. Utility of right ventricular tei index in the noninvasive evaluation of chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy A C. Cardiovascular Imaging. 2009;2(2): 143-149
Novel Pathogenesis and Treatments for Cardiovascular Disease
394
https://t.me/medicina_free
[25] Haddad F, Spruijt OA, Denault AY,
Mercier O, Brunner N, Furman D, et al. Right heart score for predicting outcome in idiopathic, familial, or drug- and toxin-associated pulmonary arterial hypertension JACC. Cardiovascular Imaging. 2015;8(6):627-638
[26] Kamimura Y, Okumura N, Adachi S,
Shimokata S, Tajima F, Nakano Y, et al. Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension. Heart and Vessels. 2018; 33:1220-1228. DOI: 10.1007/s00380-018­1168-7
[27] Badagliacca R, Papa S, Valli G,
Pezzuto B, Poscia R, Manzi G, et al. Echocardiography combined with cardiopulmonary exercise testing for the prediction of outcome in idiopathic pulmonary arterial hypertension. Chest. 2016;150(6):1313-1322. DOI: 10.1016/j. chest.2016.07.036
[28] Moceri P, Baudouy D, Chiche O,
Cerboni P, Bouvier P, Chaussade C, et al. Imaging in pulmonary hypertension: Focus on the role of echocardiography. Archives of Cardiovascular Disease. 2014;107:261-271
[29] Frost A, Badesch D, Simon J,
Gibbs R, Gopalan D, Khanna D, et al. Diagnosis of pulmonary hypertension. European Respiratory Journal. 2019;53:
1801904. DOI: 101183/13993003. 01904-20180
[30] Park J-H, Park MM, Farha S, Sharp J,
Lundgrin E, Comhair S, et al. Impaired global right ventricular longitudinal strain predicts long-term adverse outcomes in patients with pulmonary arterial hypertension. Journal of Cardiovascular Ultrasound. 2015;23(2): 91-99
[31] Badagliacca R, Pezzuto B, Papa S,
Poscia R, Manzi G, Pascaretta A, et al. Right ventricular strain curve morphology and outcome in idiopathic pulmonary arterial hypertension. Cardiovascular Imaging. 2021;14(1): 162-172
[32] Muraru D, Haugaa K, Donal E,
Stankovic I, Voigt JU, Petersen SE, et al. Right ventricular longitudinal strain in the clinical routine: A state-of-the-art review. European Heart Journal ­Cardiovascular Imaging. 2022;23(7): 898-912. DOI: 10.1093/ehjci/jeac022
[33] Ünlü S, Bézy S, Cvijic M,
Duchenne J, Delcroix M, Voigt JU. Right ventricular strain related to pulmonary artery pressure predicts clinical outcome in patients with pulmonary arterial hypertension. European Heart Journal – Cardiovascular Imaging. 2022;jeac136. DOI: 10.1093/ehjci/jeac136
[34] Murata M, Tsugu T, Kawakami T,
Kataoka M, Minakata Y, Endo J, et al. Prognostic value of three-dimensional echocardiographic right ventricular ejection fraction in patients with pulmonary arterial hypertension. Oncotarget. 2016;7(52):86781-86790
[35] Vitarelli A, Mangieri E, Terzano C ,
Gaudio C, Salsano F, Rosato E, et al. Three-dimensional echocardiography and 2D-3D speckle-tracking imaging in chronic pulmonary hypertension: Diagnostic ac curacy in detecting hemodynamic signs of right ventricular (RV) failure. Journal of the American Heart Association. 2015;4: e001584
[36] Muraru D, Badano LP, Nagata Y,
Surkova E, Nabeshima Y, Genovese D, et al. Development and prognostic validation of partition values to grade right ventricular dysfunction severity using 3D echocardiography. European
16
Echocardiographic
395
https://t.me/medicina_free
http://dx.doi.org/10.5772/.107420
DOI:
Heart
Journal - Cardiovascular Imaging.
Prognostic Factors in Pulmonary Hypertension
2020;21:10-21
Nagy VK, Széplaki G, Apor A,
[37]
Kutyifa Role longitudinal and resynchronization PlosOne.
V,
Kovács A, Kosztin A, et al.
of
right ventricular global
strain in predicting early
long-term mortality in cardiac
therapy patients.
2015. DOI: 10.1371/journal.
pone.0143907
[38]
Haddad F, Couture P, Tousignant C, Denault cardiac perspective: importance, Anesthesia
AY. The right ventricle in
surgery, a perioperative
II. Pathophysiology, clinical
and management.
and Analgesia. 2009;108(2):
422-433
Wencker D, Borer JS, Hochreiter C,
[39]
Devereux et
al. Preoperative predictors of late postoperative with with comparison Cardiology.
RB, Roman MJ, Kligfield P,
outcome among patients nonischemic mitral regurgitation high risk descriptors and
with unoperated patients. 2000;93:37-42
Navaratnam M, DiNardo JA.
[40]
Perioperative dysfunction
Cardiovascular Diagnosis and
view. Therapy. DOI:
10.21037/cdt-20-426)
right ventricular
-
The anesthesiologist’s
2020;10(5):1725-1734.
Chapter 19
396
https://t.me/medicina_free
The Association of Hair Cortisol and Cardiometabolic Risk Factors in Car
diovascular Disease
Jennifer C.Van Wyk
Abstract
Hair cortisol is increasingly becoming a reliable measure of long-term cortisol con­centration and is thought to be a suitable biomarker for chronic stress. Further, a growing amount of scientific literature links elevated hair cortisol concentration with well-known cardiometabolic risk factors such as hypertension, obesity, dyslipidemia, and diabetes. This has important implications for the prognosis, treatment, and prevention of cardio­vascular disease. This review focuses on the association between increased hair cortisol and stress-related cardiometabolic risk factors for cardiovascular disease. While the evidence for the relationship between cardiometabolic risk and elevated hair cortisol is clear and compelling, the data is inconsistent. Further studies are needed to support the use of hair cortisol as a biomarker of cardiometabolic risk in cardiovascular disease.
Keywords: cardiovascular disease, hair cortisol, cardiometabolic risk, obesity, hypertension, dyslipidemia, diabetes
. Introduction
Cardiovascular disease (CVD) continues to be the primary cause of morbidity and mortality worldwide [1]. In 2019, approximately 17.9 million people died from CVDs, representing 32% of all global deaths [2]. Eighty-five percent of CVD deaths resulted from heart attack and stroke. These high numbers are especially concerning since most CVDs are preventable or modifiable by addressing behavioral risk factors, such as a sedentary lifestyle, unhealthy diet, tobacco use, and harmful use of alcohol [1–3]. Early detection is essential in eradicating or in beginning management of cardiovas­cular disease with counseling and medications.
Cardiometabolic risk (CMR) refers to the risk factors that increase the likelihood of experiencing cardiovascular events or developing metabolic disease [4]. Besides the traditional cardiovascular risk factors (age, gender, family history, hypertension, diabetes, and smoking), CMR factors include abdominal obesity, insulin resistance, inflammation, unhealthy eating habits, and a sedentary lifestyle (Figure ). Several cross-sectional clinical studies have shown a positive association between cortisol and cardiometabolic risk factors. With stress being an integral part of modern life that has become a significant health problem [5, 6], the importance of biomark­ers that can assist in the treatment of stress-related diseases should only increase.
Novel Pathogenesis and Treatments for Cardiovascular Disease
397
https://t.me/medicina_free
Figure 1. Factors contributing to cardiometabolic risk.
In particular, hair cortisol concentration (HCC) is gaining interest as a promising biomarker for cardiometabolic risk [7]. However, research investigating the direct association between HCC and cardiometabolic risk factors is still in its infancy, and more extensive prospective cohort studies are needed to gain further insight into the relationship between HCC, CMR, and the development of CVD. Unhealthy lifestyles such as physical inactivity, smoking, and excessive alcohol use also result in elevated cortisol levels and are associated with cardiometabolic risk and cardiovascular disease [4]. However, this review focuses on biological factors linked to high cortisol levels and stress that are activated through the hypothalamic-pituitary-adrenal (HPA) axis pathway, including hypertension, obesity, dyslipidemia, and diabetes.
. Laboratory determination of hair cortisol concentration (HCC)
Different laboratories use similar methods to measure HCC with minor variations in experimental procedures. Usually, the proximal 3cm of hair which represents the last 3months of cortisol production, is collected [8, 9]. Using the most proximal seg­ments reduces the potential for a ‘wash-out effect’ which relates to a decline in cortisol levels in distal segments due to ultraviolet radiation and hair care practices [8]. The hair sample is carefully sectioned into segment lengths that approximate the period of interest, for example, cut into 1cm fragments, or whole hair samples are used. Hair grows approximately 1cm per month, so this is a convenient approximation of changes in HCC each month [9].
The hair is then either finely minced with scissors or pulverized with a ball mill. The mass of hair used for analysis varies between studies, with a range of 2.5–50mg for ELISA and 1.25–20mg for LCMS [10]. Next, the samples are incubated in a solvent such as methanol for a set period to extract the cortisol. The extraction medium is evaporated to dryness and the extracted cortisol is reconstituted in a solution such as phosphate-buffered saline or distilled water. HCC is typically measured using two types of analyses: immunoassays or mass spectrometry [9, 10]. Immunoassays used for the analysis include enzyme-linked immunosorbent assay (ELISA), immu­noassay with chemiluminescence detection (CLIA), and radioimmunoassay (RIA).
The Association of Hair Cortisol and Cardiometabolic Risk Factors in Cardiovascular… DOI: http://dx.doi.org/10.5772/.108356
Alternatively, liquid chromatography-mass spectrometry (LCMS) is used to deter-
398
https://t.me/medicina_free
mine HCC. Typically, the inter- and intra-assay coefficients of variability (cvs) are reported to indicate variability between measurements using different plates or tests and between duplicate samples on the same plate, respectively [10].
As the clinical utilization of HCC increases, it is important to establish an inter
­national benchmark [8, 9, 11]. Russell etal. conducted a study comparing the cortisol testing protocols of four leading laboratories, which include four ELISA methods and two LCMS methods, by analyzing the same hair samples representing the low, intermediate, and high ranges of hair cortisol concentrations (HCC) [9]. This study showed significant positive correlations between the four different immunoassay methods, while the results for the LCMS methods were almost identical. Further, the study concluded that laboratories using immunoassays could use a correction factor to convert results into standard LCMS equivalents.
. The role of long-term hair cortisol levels in CVD risk
Stress can be defined as any stimuli that can alter homeostasis and causes physical,
emotional, or psychological strain. It impairs both physical and physiological health [6], resulting in a higher risk for obesity, type 2 diabetes mellitus, and cardiovascular diseases [5, 6]. Stress can be the result of psychosocial factors like anxiety, social isola­tion, and traumatic life events. Although some stress is beneficial and helps the body cope (e.g., with inflammation), excessive/prolonged stress can be harmful [12–15]. The response to stress is mediated by the “stress hormone” cortisol, which is released in higher doses under an excessive amount of stress [12]. Cortisol is a lipid-soluble glucocorticoid hormone that regulates a wide range of basal processes throughout the body, including metabolism, and immune response, and, most importantly, it helps the body to respond to stress and to maintain homeostasis. Cortisol does this by increasing blood sugar through gluconeogenesis, suppressing the immune system, and increasing the metabolism of fat, glucose, protein, and carbohydrates [13]. The production of cortisol is housed in the cortex of the adrenal glands and then released into the bloodstream, which transports it throughout the body [12]. Cortisol is an end product of the Hypothalamic-Pituitary-Adrenal (HPA) axis; its secretion in response to biochemical stress may influence health and cognitive events [12, 13].
The hypothalamic-pituitary-adrenal (HPA) axis is a crucial stress response system
in the human body [12]. The primary function of the HPA axis is to maintain homeo­stasis and facilitate successful adaption to the surrounding environment through an intricate cascade of hormonal reactions. The stress response initiates when a stressor triggers the hypothalamus, releasing corticotropin-releasing factor (CRF) and vasopressin (AVP). These hormones stimulate the production of adrenocorticotropic hormone (ACTH) from the pituitary gland, eliciting the release of glucocorticoids, most notably cortisol, from the adrenal glands (Figure ). Chronic stress has been well-documented as increasing the risk of cardiovascular disease through sustained exposure to increased levels of endogenous cortisol [6, 13]. The elevation of plasma cortisol levels is one of the best-studied components of the stress response, and this hormone is one of the best indicators of acute stress in humans.
Elevated cortisol leads to downregulation of the glucocorticoid receptor and
potently affects lipid and carbohydrate metabolism [6]. Repeated or chronic stress can result in HPA axis dysfunction and cortisol remaining at high levels [12]. Clinical and population studies have shown that excessive cortisol levels are associated with
Novel Pathogenesis and Treatments for Cardiovascular Disease
399
https://t.me/medicina_free
Figure 2. The HPA axis response to stress resulting in elevated cortisol, increased cardiometabolic risk (CMR), and cardiovascular disease (CVD).
The Association of Hair Cortisol and Cardiometabolic Risk Factors in Cardiovascular… DOI: http://dx.doi.org/10.5772/.108356
developing central adiposity, insulin resistance and hyperglycemia, hypertension, and
400
https://t.me/medicina_free
dyslipidemia [14, 15]. Traditionally these studies measured cortisol levels in body flu­ids, including saliva, blood, and urine [16]. While blood and saliva samples provide a cortisol measurement of a single timepoint, urine reflects the total exposure to bioac­tive cortisol over 12 or 24hours. In contrast, hair allows for retrospective assessment of long-term cortisol concentrations over weeks, months, and even years [11, 17], potentially providing a better measure of an individual’s long-term exposure to stress. HCC is increasingly important in establishing and providing significant insight into cardiovascular disease prognosis, diagnosis, and management [13]. Elevated cortisol
Also, several cross-sectional studies found positive associations of hair cortisol with adverse cardiometabolic outcomes, including higher systolic blood pressure [18], diabetes, metabolic syndrome [18], and adiposity [18, 19].
. Association of hair cortisol with cardiometabolic risk factors
. Hypertension
Hypertension is also known as high or raised blood pressure, in which the blood
vessels have persistently raised pressure. A patient is diagnosed with hypertension when the systolic blood pressure (SBP) is above or equal to 140mm Hg and/or dia­stolic blood pressure (DBP) is above or equal to 90mm Hg [20]. If left unmanaged, hypertension can lead to a heart attack, an enlarged heart, and heart failure [21]. Hypertension can also result in kidney failure, blindness, rupture of blood vessels, and cognitive impairment. Hypertension is a critical public health and clinical condi­tion affecting billions worldwide, including approximately the 2 million Americans diagnosed annually [22]. Hypertension is one of the most prevalent risk factors for almost all cardiovascular diseases [23].
Chronic psychosocial stress is believed to increase the risk of hypertension
through sustained exposure to elevated cortisol levels [21]. Cortisol is essential for maintaining normal blood pressure but, in excess, produces hypertension [24]. In 2002, the Prospective Studies Collaboration published a meta-analysis based on 61 cohort studies showing that the risk of CVD increased steadily with progres­sively higher levels of baseline SBP and DBP; a 20mm Hg higher level of SBP and a 10mm Hg higher level of DBP resulted in a 2-fold higher BP-related absolute risk of CVD [25]. While research exploring an independent association between HCC and hypertension is still a new research area, several cross-sectional studies found a positive correlation between hair cortisol and hypertension [18, 21]. Still, the data on the relationship between blood pressure and hair cortisol level is inconsistent. While some studies reported a positive association between mean arterial or systolic blood pressure and HCC, other studies failed to demonstrate a relationship. In addition, Feller etal. found no association between prevalent hypertension and HCC and a negative relationship between objectively measured diastolic blood pressure and HCC. Hypertension prevalence was 2.23 times higher in participants with CVD [21].
. Obesity
Cardiovascular disease (CVD) is one of the primary causes of increased
morbidity and mortality in people with obesity [26, 27]. Obesity is defined as an